Newsroom

LOS ANGELES--(BUSINESS WIRE)--VRCA Investors Have the Opportunity to Join Investigation of Verrica Pharmaceuticals Inc. with the Schall Law Firm...

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) oggi ha annunciato che i dati provenienti da programmi importanti nella sua serie franchise Inflammation and Autoimmunity (IAI) verranno presentati al Meeting annuale 2026 della American Academy of Dermatology (AAD), che si svolgerà a Denver dal 27 al 31 marzo 2026. “All'AAD 2026, presenteremo gli ultimi risultati ottenuti in 54 settimane dal programma di Fase 3 STOP‑HS di valutazione del povorcitinib nell'idrosadenite suppurativa (HS)”, h...

WILMINGTON, Delaware--(BUSINESS WIRE)--Incyte (Nasdaq : INCY) a annoncé aujourd’hui que les données issues des programmes clés de sa division Inflammation et Auto-immunité (IAI) seront présentées lors du congrès annuel 2026 de l’Académie américaine de dermatologie (AAD), qui se tiendra du 27 au 31 mars 2026 à Denver. « Lors de l’AAD 2026, nous présenterons les derniers résultats à 54 semaines du programme de phase 3 STOP-HS évaluant le povorcitinib dans l’hidradénite suppurée (HS) », déclare Ji...

WILMINGTON, Delaware--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) gab heute die Vorstellung von Daten aus Schlüsselprogrammen seines Franchise-Bereichs Entzündungen und Autoimmunität (Inflammation and Autoimmunity, IAI) auf der Jahrestagung 2026 der American Academy of Dermatology (AAD) bekannt, die vom 27. bis 31. März 2026 in Denver stattfinden wird. „Auf der AAD 2026 werden wir die neuesten 54-Wochen-Ergebnisse aus dem Phase-3-STOP-HS-Programm zur Bewertung von Pavorcitinib bei Hidradenitis suppur...

WILMINGTON, Delaware--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) ha anunciado hoy que los datos de los programas primordiales de su franquicia de Inflamación y Autoinmunidad (IAI) se presentarán en el Congreso Anual de la Academia Estadounidense de Dermatología (American Academy of Dermatology, AAD) de 2026, que se realizará del 27 al 31 de marzo de 2026, en Denver. "En la AAD 2026, presentaremos los últimos resultados a las 54 semanas del programa de fase III STOP-HS, que evalúa la administración d...

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) maakte vandaag bekend dat gegevens uit belangrijke programma's in haar IAI-franchise (Inflammation & Autoimmunity) zullen worden voorgesteld tijdens de 2026 AAS (American Academy of Dermatology) Annual Meeting, die van 27 tot 31 maart 2026 doorgaat in Denver. “Op AAD 2026 stellen we zeer recente resultaten uit de 54 weken voor van het Fase 3 STOP‑HS programma, waarin povorcitinib wordt geëvalueerd bij hidradenitis suppurativa (HS),” ve...

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of TruBridge, Inc. (“TruBridge” or the “Company”) (NASDAQ: TBRG) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON TRUBRIDGE, INC. (TBRG), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On March 16, 2026, TruBridge disclosed that it would be unable to timel...

OMAHA, Neb.--(BUSINESS WIRE)--Union Pacific Railroad, founded by President Abraham Lincoln in 1862, unveiled its plans today to celebrate the United States, its amazing history and the people behind its unparalleled success story with two new locomotives and the first Big Boy steam tour to the East Coast in honor of America’s 250th anniversary. Big Boy, the world’s largest operating steam locomotive, will journey to Philadelphia for Fourth of July, with stops planned in Illinois, Indiana, Ohio,...

NEW DELHI--(BUSINESS WIRE)--Fortis Healthcare vient de recevoir six prix prestigieux au FICCI Advantage Healthcare India 2026, le sommet international sur les voyages médicaux , soulignant son leadership et son excellence dans la prestation de soins de santé à l'échelle mondiale. Ces distinctions, présentées lors du sommet de trois jours qui s’est tenu du 23 au 25 février 2026 dans le cadre des FICCI Medical Value Travel Awards, consolident la réputation de Fortis en tant que partenaire de conf...

ATLANTA--(BUSINESS WIRE)--Volato Group, Inc. (the “Company” or “Volato”) (NYSE American: SOAR) today announced that on March 17, 2026, it received a notice (the “notice”) from the NYSE American LLC (the “NYSE American”) advising the Company that it is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide (the “Company Guide”) requiring a company to have stockholders’ equity of at least $2.0 million if it has repor...